Helsinn, Otsuka Holdings sales and marketing update

Helsinn said Otsuka's Taiho Pharmaceutical Co. Ltd. subsidiary launched a 0.75 mg infusion bag formulation of Aloxi palonosetron in Japan to prevent chemotherapy-induced nausea and vomiting (CINV) i...